Published in Pediatr Clin North Am on June 01, 1988
Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol (1990) 2.72
Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol (1994) 2.22
Cloning and expression of a gene encoding an integrin-like protein in Candida albicans. Proc Natl Acad Sci U S A (1996) 1.88
Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev (1994) 1.76
PCR identification of four medically important Candida species by using a single primer pair. J Clin Microbiol (1994) 1.72
Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest (1991) 1.68
Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun (2001) 1.34
Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin Microbiol (1997) 1.27
Investigation of Candida albicans transmission in a surgical intensive care unit cluster by using genomic DNA typing methods. J Clin Microbiol (1995) 1.23
Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis. Identification of the participating ligands and development of inhibitory peptides. J Clin Invest (1993) 1.11
Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol (1999) 1.08
Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis. Antimicrob Agents Chemother (1994) 1.04
Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol (1998) 0.97
Antifungal agents for common paediatric infections. Can J Infect Dis Med Microbiol (2008) 0.93
Trends in epidemiology of neonatal sepsis in a tertiary center in Korea: a 26-year longitudinal analysis, 1980-2005. J Korean Med Sci (2011) 0.93
Enhanced killing of Candida albicans by human macrophages adherent to type 1 collagen matrices via induction of phagolysosomal fusion. Infect Immun (2005) 0.92
Systemic fungal infections in neonates. Arch Dis Child (1994) 0.89
Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother (1995) 0.82
Adhesion of Candida albicans to brain tissue of Macaca mulata in an ex vivo assay. Infect Immun (1995) 0.78
Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics. Int J Microbiol (2013) 0.76
Intracardiac Fungal Mass in a Term Neonate. Methodist Debakey Cardiovasc J (2017) 0.75
Antifungal agents for common paediatric infections. Paediatr Child Health (2007) 0.75
"Amber in chamber" an enigmatous right atrial mass in a neonate. Saudi J Anaesth (2015) 0.75
Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med (1976) 5.78
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol (1977) 4.46
Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42
Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71
Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J Clin Microbiol (1993) 3.52
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Rev Infect Dis (1983) 3.23
Active oxygen in plant pathogenesis. Annu Rev Phytopathol (1995) 3.02
Molecular cloning of a Pseudomonas syringae pv. syringae gene cluster that enables Pseudomonas fluorescens to elicit the hypersensitive response in tobacco plants. J Bacteriol (1988) 2.84
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Involvement of plasma membrane calcium influx in bacterial induction of the k/h and hypersensitive responses in tobacco. Plant Physiol (1990) 2.46
Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr (1993) 2.45
Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun (1976) 2.38
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15
Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol (1976) 2.14
Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05
The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. Pediatrics (1997) 2.04
Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA (1998) 2.00
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother (1998) 2.00
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J Clin Microbiol (1989) 1.87
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics (1989) 1.78
Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis (1977) 1.76
Group B streptococcal vaccines. Rev Infect Dis (1985) 1.74
Group B streptococcal infections. Adv Intern Med (1980) 1.72
Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother (1976) 1.72
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
Group B streptococcal cellulitis-adenitis in infants. Am J Dis Child (1982) 1.71
Single oral dose metronidazole therapy for Gardnerella vaginalis vaginitis in adolescent females. J Adolesc Health Care (1983) 1.70
Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun (1991) 1.64
Congenital ring constrictions and intrauterine amputations. Am J Dis Child (1971) 1.62
Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis (2000) 1.53
Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis (1987) 1.51
Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr (1985) 1.49
Commercial latex agglutination for detection of group B streptococcal antigen in body fluids. J Pediatr (1983) 1.47
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. J Clin Invest (1982) 1.47
Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis (1994) 1.43
A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res (1987) 1.42
Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis (1996) 1.41
Immune response of infants and children to disseminated infections with Neisseria meningitidis. J Infect Dis (1984) 1.41
Identification of sialic acid in polysaccharide antigens in group B Streptococcus. Infect Immun (1976) 1.38
Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol (2000) 1.36
Variations in HIV risk behaviors of incarcerated juveniles during a four-year period: 1989-1992. J Adolesc Health (1998) 1.36
Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics (2000) 1.35
Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis (2001) 1.33
Methylobacterium mesophilica as a cause of persistent bacteremia in a child with lymphoma. Pediatr Infect Dis J (1997) 1.33
Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA (1984) 1.31
Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera. J Infect Dis (1980) 1.27
Transient Activation of Plasmalemma K Efflux and H Influx in Tobacco by a Pectate Lyase Isozyme from Erwinia chrysanthemi. Plant Physiol (1986) 1.26
Electron microscopic definition of surface antigens of group B Streptococcus. J Infect Dis (1979) 1.25
Sialylation and human neutrophil killing of group C Neisseria meningitidis. J Infect Dis (1992) 1.24
Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J Infect Dis (1990) 1.24
Invasive group B streptococcal disease in children beyond early infancy. Pediatr Infect Dis J (1995) 1.24
Candidal meningitis in neonates: a 10-year review. Clin Infect Dis (2000) 1.24
Complications and sequelae of meningococcal infections in children. J Pediatr (1981) 1.23
Neonatal meningitis due to Lactobacillus. Pediatr Infect Dis (1983) 1.22
Prospective diagnosis of early onset group B streptococcal infection by countercurrent immunoelectrophoresis. J Pediatr (1979) 1.22
Antibody to group B Streptococcus type III in human sera measured by a mouse protection test. Infect Immun (1981) 1.22
Role of the Plasmalemma H-ATPase in Pseudomonas syringae-Induced K/H Exchange in Suspension-Cultured Tobacco Cells. Plant Physiol (1989) 1.21
Comparison of slide coagglutination test and countercurrent immunoelectrophoresis for detection of group B streptococcal antigen in cerebrospinal fluid from infants with meningitis. J Clin Microbiol (1980) 1.19
Commercial latex agglutination test for rapid diagnosis of group B streptococcal infection in infants. J Clin Microbiol (1980) 1.19
Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants. J Immunol (1978) 1.18
Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed (2003) 1.18
Potentiation of virulence by group B streptococcal polysaccharides. J Infect Dis (1984) 1.17
Group B streptococcal infection in newborns: prevention at last? N Engl J Med (1986) 1.16
An etiologic shift in infantile osteomyelitis: the emergence of the group B streptococcus. J Pediatr (1978) 1.15
Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. J Clin Invest (1983) 1.15
Deposition and degradation of C3 on type III group B streptococci. Infect Immun (1991) 1.15
Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis (2001) 1.15
Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci. Infect Immun (1992) 1.14
Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus. J Infect Dis (1977) 1.13
The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Am J Obstet Gynecol (1980) 1.11
The role of complement and antibody in opsonophagocytosis of type II group B streptococci. J Infect Dis (1986) 1.10
Prevention of group B streptococcal infection. Infect Dis Clin North Am (1992) 1.09
Early onset group B streptococcal disease. J Pediatr (1978) 1.08
Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. N Engl J Med (1980) 1.07
Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics (1990) 1.07
Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease. Pediatrics (1980) 1.06
Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects. J Pediatr (1994) 1.04
Antibody-independent activation of C1 by type Ia group B streptococci. J Infect Dis (1982) 1.04
Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci. Antimicrob Agents Chemother (1981) 1.04
Bacillus species infections in neonates. Rev Infect Dis (1989) 1.03
Recurrent group B streptococcal disease in infants: Who should receive rifampin? J Pediatr (1998) 1.03
Colonization with group B streptococci in girls under 16 years of age. Pediatrics (1977) 1.01
The influence of advancing gestation on group B streptococcal colonization in pregnant women. Am J Obstet Gynecol (1975) 1.01
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. J Infect Dis (2000) 1.01
Cerebrospinal fluid C-reactive protein in neonatal meningitis. J Pediatr (1983) 1.00
Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates. Indian J Med Res (2004) 0.99
Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun (1996) 0.99
Pelvic osteomyelitis in children. Pediatrics (1978) 0.99